News

The University of Gothenburg relies on technology from Biognosys

According to a press release, the Schlieren-based biotech company Biognosys has fully equipped the first laboratory in Europe with its P2 plasma enrichment system. The system has been installed at the Proteomics Core Facility at the University of Gothenburg. This is an important step in making Biognosys' P2 technology more...

read more

CUTISS completes patient recruitment in Phase 2 pediatric burns trial

CUTISS has completed patient recruitment in its Phase 2 clinical trial evaluating the safety and efficacy of denovoSkin™ in children with severe burns. This randomized, controlled trial compares denovoSkin™ to the current standard of care, autografting, using an intra-patient control design. It is one of three Phase 2 trials designed to...

read more

Lightium wins the 32nd Prix Strategis

Lightium won the Prix Strategis 2025. The startup develops photonic chips for telecommunications and artificial intelligence. The Strategis Prize is awarded by HEC Espace Entreprise in Lausanne. Lightium, a start-up that specializes in photonic integrated circuits, won the Prix Strategis for the 32nd time this year. Based in the Bio-Technopark Schlieren-Zurich,...

read more

CUTISS granted U.S. patent for automation technology in skin tissue therapy

CUTISS has been granted a new patent in the United States for a core element of its automated platform used to manufacture personalized, bio-engineered human skin grafts. The patent (US Patent No. 12,286,611), titled “Tissue culture vessel for preparation of compressed hydrogel skin grafts and related methods and systems,” protects a...

read more